A Washington Post editorial today warns us that allowing Medicare to negotiate prices directly with the pharmaceutical industry would be "a sure way of flooding the political system with yet more pharmaceutical lobbyists and campaign spending." Those of us who live in Washington know that the industry already floods the political system in order to preserve and strengthen the government granted patent protection that allows them to charge monopoly prices. Taking the money away will reduce, not increase, the number of lobbyists.
--Dean Baker